NuvOx Pharma Revenue and Competitors
Estimated Revenue & Valuation
- NuvOx Pharma's estimated annual revenue is currently $2.4M per year.
- NuvOx Pharma's estimated revenue per employee is $201,000
Employee Data
- NuvOx Pharma has 12 Employees.
- NuvOx Pharma grew their employee count by 9% last year.
NuvOx Pharma's People
| Name | Title | Email/Phone |
|---|---|---|
1 | President and CEO | Reveal Email/Phone |
2 | Operations Associate | Reveal Email/Phone |
NuvOx Pharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $26.3M | 131 | 18% | N/A | N/A |
#2 | $17.7M | 88 | 0% | N/A | N/A |
#3 | $8M | 40 | -9% | N/A | N/A |
#4 | $35.2M | 175 | 47% | N/A | N/A |
#5 | $1.4M | 7 | -53% | N/A | N/A |
#6 | $2.4M | 12 | 9% | N/A | N/A |
#7 | $4.6M | 23 | -4% | N/A | N/A |
#8 | $37.4M | 186 | 8% | N/A | N/A |
#9 | $53.7M | 267 | 16% | N/A | N/A |
#10 | $2.6M | 13 | -19% | N/A | N/A |
What Is NuvOx Pharma?
NuvOx Pharma is a biotechnology company based in Tucson, Arizona that is developing a first-in-class oxygen therapeutic to treat life-threatening diseases where hypoxia plays a role. Over 30 animal studies have shown therapeutic effect in seven different indications. Phase Ib/II clinical trials in stroke and oncology demonstrated safety and evidence of efficacy, and the company is preparing to run a Phase IIa trial in COVID-19 patients with Acute Hypoxemic Respiratory Failure (AHRF). *Cover photo painting by Diane Fairfield
keywords:N/A
N/A
Total Funding
12
Number of Employees
$2.4M
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
NuvOx Pharma News
alliance pharma plc, baxter, NuvOx Pharma, Sanguine Biosciences, Therapure Biopharma Inc, Hemarina, Hemoglobin Oxygen Therapeutics,...
NuvOx Pharma's technology, which is developed as a first-in-class therapeutic to treat life-threatening diseases where hypoxia plays a role,...
NuvOx Pharma, a clinical stage biotechnology company developing a first-in-class therapeutic to treat life-threatening diseases where...
Other Companies in Tucson
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.1M | 12 | 0% | N/A |
#2 | $1.7M | 12 | 0% | N/A |
#3 | $1M | 12 | -20% | N/A |
#4 | $1M | 12 | -14% | N/A |
#5 | $1.9M | 12 | 20% | N/A |